Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   3,7-Dihydroxytropolones Inhibit Initiation of Hepatitis B Virus Minus-Strand DNA Synthesis
  2. Bak, Ellen; Miller,Jennifer; Noronha, Andrea; Tavis, John; Gallicchio, Emilio; Murelli, Ryan P; Le Grice,Stuart
  3. Molecules (Basel, Switzerland). 2020, OCT; 25(19): pii: E4434.
  1. 2.   Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription
  2. Henriet, S.; Sinck, L.; Bec, G.; Gorelick, R. J.; Marquet, R.; Paillart, J. C.
  3. Nucleic Acids Research. 2007, Aug; 35(15): 5141-5153.
  1. 3.   Effects of mutations in the human immunodeficiency virus type 1 gag gene on RNA packaging and recombination
  2. Nikolaitchik, O.; Rhodes, T. D.; Ott, D.; Hu, W. S.
  3. Journal of Virology. 2006, MAY; 80(10): 4691-4697.
  1. 4.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
  1. 5.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 6.   Alternate polypurine tracts (PPTs) affect the Rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction
  2. Chang, K. W.; Julias, J. G.; Alvord, W. G.; Oh, J.; Hughes, S. H.
  3. Journal of Virology. 2005, NOV; 79(21): 13694-13704.
  1. 7.   Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
  2. Shebzukhov, Y. V.; Koroleva, E. P.; Khlgatian, S. V.; Lagarkova, M. A.; Meshcheryakov, A. A.; Lichinitser, M. R.; Karbach, J.; Jager, E.; Kuprash, D. V.; Nedospasov, S. A.
  3. Immunology Letters. 2005, AUG 15; 100(1): 88-93.
  1. 8.   A mechanism of palindromic gene amplification in Saccharomyces cerevisiae
  2. Rattray, A. J.; Shafer, B. K.; Neelam, B.; Strathern, J. N.
  3. Genes & Development. 2005, JUN 1; 19(11): 1390-1399.
  1. 9.   Formylpeptide receptor FPR and the rapid growth of malignant human gliomas
  2. Zhou, Y.; Bian, X. W.; Le, Y. Y.; Gong, W. H.; Hu, J. Y.; Zhang, X.; Wang, L. H.; Iribarren, P.; Salcedo, R.; Howard, O. M. Z.; Farrar, W.; Wang, J. M.
  3. Journal of the National Cancer Institute. 2005, JUN 1; 97(11): 823-835.
  1. 10.   Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis
  2. Beltz, H.; Clauss, C.; Piemont, E.; Ficheux, D.; Gorelick, R. J.; Roques, B.; Gabus, C.; Darlix, J. L.; de Rocquigny, H.; Mely, Y.
  3. Journal of Molecular Biology. 2005, MAY 20; 348(5): 1113-1126.
  1. 11.   Attenuation of DNA replication by HIV-1 reverse transcriptase near the central termination sequence
  2. Ignatov, M. E.; Berdis, A. J.; Le Grice, S. F. J.; Barkley, M. D.
  3. Biochemistry. 2005, APR 12; 44(14): 5346-5356.
  1. 12.   Determination of the stability constants and oxidation susceptibility of nickel(II) complexes with 2 '-de oxyguano sine 5 '-triphosphate and L-histidine
  2. Kaczmarek, P.; Jezowska-Bojczuk, M.; Bal, W.; Kasprzak, K. S.
  3. Journal of Inorganic Biochemistry. 2005, MAR; 99(3): 737-746.
  1. 13.   Mechanism for nucleoside analog-mediated abrogation of HIV-1 replication: Balance between RNase H activity and nucleotide excision
  2. Nikolenko, G. N.; Palmer, S.; Maldarelli, F.; Mellors, J. W.; Coffin, J. M.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 8; 102(6): 2093-2098.
  1. 14.   Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases
  2. Boyer, P. L.; Julias, J. G.; Marquez, V. E.; Hughes, S. H.
  3. Journal of Molecular Biology. 2005, JAN 21; 345(3): 441-450.
  1. 15.   Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer
  2. Mbisa, J. L.; Nikolenko, G. N.; Pathak, V. K.
  3. Journal of Virology. 2005, JAN; 79(1): 419-427.
  1. 16.   Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase
  2. Bibillo, A.; Lener, D.; Klarmann, G. J.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2005 33(1): 171-181.
  1. 17.   Cooperative effect of Gag proteins p12 and capsid during early events of murine leukemia virus replication
  2. Lee, S. K.; Nagashima, K.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4159-4169.
  1. 18.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 19.   Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
  2. Luo, K.; Liu, B. D.; Xiao, Z. X.; Yu, Y. K.; Yu, X. H.; Gorelick, R.; Yu, X. F.
  3. Journal of Virology. 2004, NOV; 78(21): 11841-11852.
  1. 20.   Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3 ' polypurine tract
  2. Dash, C.; Rausch, J. W.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2004 32(4): 1539-1547.
  1. 21.   Mutations at position 184 of human immunodeficiency virus type-1 reverse transcriptase affect virus titer and viral DNA synthesis
  2. Julias, J. G.; Boyer, P. L.; McWilliams, M. J.; Alvord, W. G.; Hughes, S. H.
  3. Virology. 2004 322(1): 13-21.
  1. 22.   Synthetic tRNA(Lys,3) as the replication primer for the HIV-1(HXB2) and HIV-1(Mal) genomes
  2. Miller, J. T.; Khvorova, A.; Scaringe, S. A.; Le Grice, S. F. J.
  3. Nucleic Acids Research. 2004 32(15): 4687-4695.
  1. 23.   Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins
  2. Chertova, E.; Crise, B. J.; Morcock, D. R.; Bess, J. W.; Henderson, L. E.; Lifson, J. D.
  3. Current Molecular Medicine. 2003 3(3): 265-272.
  1. 24.   Retroviral recombination: Review of genetic analyses
  2. Hu, W. S.; Rhodes, T.; Dang, Q.; Pathak, V.
  3. Frontiers in Bioscience. 2003 8: D143-D155.
  1. 25.   A novel putative transcription factor protein MYT2 that preferentially binds supercoiled DNA and induces DNA synthesis in quiescent cells
  2. Shao, W.; Lee, A. Y.; Gulnik, S.; Gustchina, E.; Liu, Y. L.; Kung, H. F.; Erickson, J. W.
  3. Febs Letters. 2000 473(3): 363-369.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel